Literature DB >> 192917

Analysis of intracellular feline leukemia virus proteins II. Generation of feline leukemia virus structural proteins from precursor polypeptides.

G F Okasinski, L F Velicer.   

Abstract

The synthesis and processing of feline leukemia virus (FeLV) polypeptides were studied in a chronically infected feline thymus tumor cell line, F-422, which produces the Rickard strain of FeLV. Immune precipitation with antiserum to FeLV p30 and subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were used to isolate intracellular FeLV p30 and possible precursor polypeptides. SDS-PAGE of immune precipitates from cells pulse-labeled for 2.5 min with [35S]methionin revealed the presence of a 60,000-dalton precursor polypeptide (Pp60) as well as a 30,000-dalton polypeptide. When cells were grown in the presence of the proline analogue L-azetidine-2-carboxylic acid, a 70,000-dalton precursor polypeptide (Pp70) was found in addition to Pp60 after a 2.5-min pulse. The cleavage of Pp60 could be partially inhibited by the general protease inhibitor phenyl methyl sulfonyl fluoride (PMSF). This partial inhibition was found to occur only if PMSF was present during pulse-labeling. Intracellular Pp70 and Pp60 and FeLV virion p70, p30, p15, p11, and p10 were subjected to tryptic peptide analysis. The results of this tryptic peptide analysis demonstrated that intracellular Pp70 and virion p70 were identical and that both contained the tryptic peptides of FeLV p30, p15, p11, and p10. Pp60 contained the tryptic peptides of FeLV P30, P15, and P10, but lacked the tryptic peptides of P11. The results of pactamycin gene ordering experiments indicated that the small structural proteins of FeLV are ordered p11-p15-p10-p30. The data indicate that the small structural proteins of FeLV are synthesized as part of a 70,000-dalton precursor. A cleavage scheme for the generation of FeLV p70, p30, p15, p11, and p10 from precursor polypeptides is proposed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192917      PMCID: PMC515687     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Proteins of Rauscher murine leukemia virus: resolution of a 70,000-dalton, Nonglycosylated polypeptide containing p30 peptide sequences.

Authors:  G Jamjoom; W L Karshin; R B Naso; L J Arcement; R B Arlinghaus
Journal:  Virology       Date:  1975-11       Impact factor: 3.616

2.  Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus.

Authors:  D Zaanie; A L Gielkens; M J Dekker-michielsen; H P Bloemers
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

3.  Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro.

Authors:  A L Gielkens; D Van Zaane; H P Bloemers; H Bloemendal
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

4.  Translation of Rous sarcoma virus RNA in a cell-free system from ascites Krebs II cells.

Authors:  K von der Helm; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

5.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

6.  Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.

Authors:  L J Arcement; W L Karshin; R B Naso; G Jamjoom; R B Arlinghaus
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

7.  Inhibition of eukaryotic DNA-dependent RNA polymerase release from isolated nuclei and nucleoli by phenylmethylsulfonylfluoride.

Authors:  T J Lindell
Journal:  Arch Biochem Biophys       Date:  1975-11       Impact factor: 4.013

8.  Tryptic peptide analysis on nonstructural and structural precursor proteins from Semliki Forest virus mutant-infected cells.

Authors:  B E Lachmi; N Glanville; S Keränen; L Lääriäinen
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

9.  The cell-free translation of Rauscher leukemia virus RNA into high molecular weight polypeptides.

Authors:  R B Naso; L J Arcement; G Wood; T E Saunders; R B Arlinghaus
Journal:  Biochim Biophys Acta       Date:  1975-03-10

10.  Translation of murine leukemia virus RNA in cell-free systems from animal cells.

Authors:  I M Kerr; U Olshevsky; H F Lodish; D Baltimore
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

View more
  5 in total

1.  Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.

Authors:  C J Sherr; A Sen; G J Todaro; A Sliski; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Analysis of cytoplasmic RNA and polyribosmomes from feline leukemia virus-infected cells.

Authors:  A J Conely; L F Velicer
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

3.  Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.

Authors:  C J Sherr; G J Todaro; A Sliski; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins.

Authors:  A S Khan; J R Stephenson
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

Review 5.  The immunobiology of the feline leukemia virus.

Authors:  J L Rojko; R G Olsen
Journal:  Vet Immunol Immunopathol       Date:  1984-05       Impact factor: 2.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.